Literature DB >> 17589130

The medically important yeasts present in clinical specimens.

S S Al-Hedaithy1.   

Abstract

In an effort to determine the yeast species present in clinical specimens obtained from patients attending a busy Saudi hospital, the present study was undertaken. More than 1614 yeasts were isolated in culture from pathologic specimens of over 1303 patients with diverse clinical conditions. Organisms identified in 22 species of eight general included: Candida albicans, C. parapsilosis, C. tropicalis, C. krusei, C. lipolytica, C. guilliermondii, C. pseudotropicalis, C. pinotolopesii, C. humicola, C. stellatoidea, C. lusitaniae, Torulopsis glabrata, T. inconspicua, T. candida, Trichosporon beigelii, T. capitatum, Saccharomyces cerevisiae, Cryptococcus neoformans, C. albidus, Rhodotorula glutinis, Hansenula anomala and Prototheca zopfii. The details of specimen types yielding these yeasts in culture are presented in the text. The most frequently isolated yeasts was C. albicans, followed by T. glabrata, C. parapsolosis, C. tropicalis, T. inconspicua, C. krusei, S. cerevisiae, T. candida, and T. beigelii. Twenty isolates of six species were recovered from blood of which C. albicans was also the most common. Crytococcus neoformans was found causing cryptococcal meningitis being isolated from the CSF on an 8-year-old female patient. Future studied assessing the incidence of yeast infections in each homogeneous group of patients are recommended.

Entities:  

Year:  1992        PMID: 17589130     DOI: 10.5144/0256-4947.1992.57

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


  2 in total

1.  Intracranial mycotic infections in neurosurgical practice.

Authors:  A B Jamjoom; S A al-Hedaithy; Z A Jamjoom; M al-Hedaithy; S F el-Watidy; N Rahman; M al-Moallem
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 2.  New and emerging yeast pathogens.

Authors:  K C Hazen
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.